ARIELLE HOLLOWAY: Open Payments
NPI 1487221537 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 97 payments from 15 companies in 2025. Trend: 2023 $1,954 · 2024 $1,608 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $455 |
| UCB, Inc. | 14 | $299 |
| Amgen Inc. | 16 | $286 |
| E.R. Squibb & Sons, L.L.C. | 13 | $284 |
| GlaxoSmithKline, LLC. | 10 | $142 |
| PFIZER INC. | 4 | $92 |
| Mallinckrodt Hospital Products Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 2 | $39 |
| SCILEX PHARMACEUTICALS INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: Bimzelx, ORENCIA, RINVOQ, SKYRIZI, BENLYSTA, OTEZLA, KRYSTEXXA, XELJANZ.
Industry payments across AR — which companies pay providers there.
